| 产品编号 | CFN70256 | |
| CAS编号 | 1055329-49-1 | |
| 分子式 = 分子量 | C36H58O9 = 634.9 | |
| 产品纯度 | >=98% | |
| 物理属性 | Powder | |
| 化合物类型 | Triterpenoids | |
| 植物来源 | The herbs of Sutherlandia frutescens | |
| ChemFaces的产品在影响因子大于5的优秀和顶级科学期刊中被引用 | ||
| 产品名称 | 产品编号 | CAS编号 | 包装 | QQ客服 |
| Sutherlandioside D | CFN70256 | 1055329-49-1 | 1mg | QQ客服:2056216494 |
| Sutherlandioside D | CFN70256 | 1055329-49-1 | 5mg | QQ客服:2056216494 |
| Sutherlandioside D | CFN70256 | 1055329-49-1 | 10mg | QQ客服:2056216494 |
| Sutherlandioside D | CFN70256 | 1055329-49-1 | 20mg | QQ客服:2056216494 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)| Description: | Sutherlandioside D may exert anti-cancer effect by targeting Gli/Hh signaling. |
| Targets: | Gli/Hh |
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 1.5751 mL | 7.8753 mL | 15.7505 mL | 31.501 mL | 39.3763 mL |
| 5 mM | 0.315 mL | 1.5751 mL | 3.1501 mL | 6.3002 mL | 7.8753 mL |
| 10 mM | 0.1575 mL | 0.7875 mL | 1.5751 mL | 3.1501 mL | 3.9376 mL |
| 50 mM | 0.0315 mL | 0.1575 mL | 0.315 mL | 0.63 mL | 0.7875 mL |
| 100 mM | 0.0158 mL | 0.0788 mL | 0.1575 mL | 0.315 mL | 0.3938 mL |
| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 六氢姜黄素; Hexahydrocurcumin | CFN97749 | 36062-05-2 | C21H26O6 = 374.43 | 10mg | QQ客服:3257982914 |
| 澳白檀苷; Lanceolarin | CFN95166 | 15914-68-8 | C27H30O14 = 578.5 | 5mg | QQ客服:1457312923 |
| 表油菜素内酯; Epibrassinolide | CFN80268 | 72962-43-7 | C28H48O6 = 480.34 | 5mg | QQ客服:1457312923 |
| 甲基 4-咖啡酰奎尼酸酯; Methyl 4-caffeoylquinate | CFN92528 | 123372-74-7 | C17H20O9 = 368.3 | 5mg | QQ客服:1457312923 |